Abstract: Provided among other things is a sampling system for determining an amount or type of contamination a narrow, elongated passageway in a medical device, said sampling system comprising: (a) a fluid supply system that supplies to said passageway a sampling liquid for flowing through said passageway and a gas for flowing through said passageway; and (b) a receiving container that receives liquid from said passageway, wherein said sampling liquid is sterile, wherein said sampling liquid is configured to allow recovery of viable pathogens from the passageway, and wherein said sampling liquid comprises an amount and selection of surfactant effective to enhance the dislodgement of Enterococcus faecalis and Pseudomonas aeruginosa bacteria from the narrow passageways.

Abstract: A cartridge is provided for dialysis or other blood processing therapy. In the cartridge, fibers may be substantially uniformly distributed near a midplane, but near an end, in the inter fiber space, there may be void flow channels, which may cause fluid flow in the inter fiber space to transition within a short region to uniform flow with minimal stagnation zones. Void flow channels may be be radially oriented, introducing fluid from the outer circumference, or axially oriented, introducing fluid along the axial direction through passageways through the potting material. The fluid flow in the inter fiber space may be perpendicular to the fibers, or radial with respect to a cartridge longitudinal axis. The cartridge may have blood flow in the inter fiber space, and flow of dialysate or ultrafiltrate in the lumens of the fibers, or the opposite situation.

Abstract: Embodiments of the invention pertain to cartridges, systems and methods for performing hemodialysis and related extracorporeal blood treatment modalities and therapies, in which blood flows in the inter fiber space and dialysate flows in the lumens of hollow fibers. Appropriate connectors and fitting orientations may be provided. There may be provided orbital distributors, fanning of fibers, and features to promote uniformity of fiber spacing in the fiber bundle. Orbital distributors may contain contoured surfaces, flow redirectors, non-uniform-conductance flow elements, through-wall distributors, and other features. There may be subdivision of the fiber bundle into two groups of fibers with separate control fluid to each group. Appropriate systems may be provided for various therapies. Flow past the fibers may be parallel, transverse or other configuration.

Abstract: A tympanostomy tube containing a polymeric material and a drug is described. The polymeric material may comprise a non-resorbable polymer and a water-soluble polymer. The drug may be released when the device is contacted by an aqueous liquid such as middle ear exudate during otitis media. The implant may contain sufficient drug to treat multiple episodes of otitis media or to catch subsequent episodes in their early stages as a prophylactic. The device may be hydrophilic and further may contain a surfactant. The implant may be porous. The implant may have enhanced surface area at places exposed to middle ear liquid and may have enlarged mass so as to contain an increased total amount of drug. Intentional reorientation of the patient's head may aid in moving drug-containing liquid around the middle ear cavity. Similar implants can be used in other mucosal cavities.

Abstract: In embodiments of the invention, there is provided a dialyzer or filter comprising hollow fibers, in which blood flows on the exterior of the hollow fibers, and dialysate or filtrate may flow on the inside. The external surfaces of the hollow fibers may have properties of smoothness and hemocompatibility. The fiber bundle may have appropriate packing fraction and may have wavy fibers. Optimum shear rates and blood velocities are identified. Geometric features of the cartridge, such as pertaining to flow distribution of the blood, may be different for different ends of the cartridge. Air bleed and emboli traps may be provided. Lengthened service life may be achieved by combinations of these features, which may permit additional therapies and applications or better economics.

Abstract: Polymeric articles capable of releasing drugs at therapeutic levels over extended periods of time, and methods for producing the extended release articles.

Abstract: An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus infections using polybiguanide-based compounds administering a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof The invention relies on the unique biochemical reaction in which polybiguanide-based compounds interfere with the spread of virus within or between organisms. The compositions and formulations described in the present invention are effective means to reduce the infectivity of the human immunodeficiency virus type 1 (HIV-1), and human herpes simplex viruses, and also to kill the causative organisms of many other sexually transmitted diseases (STDs).

Abstract: Polymeric articles capable of releasing drugs at therapeutic levels over extended periods of time, and methods for producing the extended release articles.

Abstract: An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus infections using polybiguanide-based compounds administering a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof. The invention relies on the unique biochemical reaction in which polybiguanide-based compounds interfere with the spread of virus within or between organisms. The compositions and formulations described in the present invention are effective means to reduce the infectivity of the human immunodeficiency virus type 1 (HIV-1), and human herpes simplex viruses, and also to kill the causative organisms of many other sexually transmitted diseases (STDs).

Abstract: An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus infections using polybiguanide-based compounds administering a therapeutically effective amount of a compound or a pharmaceutically acceptable salt thereof. The invention relies on the unique biochemical reaction in which polybiguanide-based compounds interfere with the spread of virus within or between organisms. The compositions and formulations described in the present invention are effective means to reduce the infectivity of the human immunodeficiency virus type 1 (HIV-1), and human herpes simplex viruses, and also to kill the causative organisms of many other sexually transmitted diseases (STDs).

Abstract: A compatibilizer and process for use in making crumb rubber modified asphalt. The compatibilizer causes the crumb rubber to completely interact with the asphalt, thereby improving the rheological properties of the asphalt and reducing the tendency of pavement made with the asphalt to ravel. The compatibilizer has as its reactive component one or more glycidyl groups; its polymeric backbone can be ethylenic, styrenic, or acrylic or ethylene vinyl acetate (EVA).

Abstract: Fiber-reinforced titanium alloy and intermetallic matrix composites having improved stability and tensile strength properties at elevated temperatures. The base reinforced fibers are pre-coated with a tailorable tri-layer coating, such as Ti--TiN--Ti. Preferably the TiN layer is graded so as to have metal-rich outer surfaces, such as titanium-rich TiN, providing excellent bonding affinity for the base titanium layer, bonded to the surface of the fibers, such as silicon carbide, and for the outer titanium layer, bonded to the titanium aluminum matrix, and a compound core, such as stoichiometric TiN, providing a stable interfacial barrier against chemical reactions, whereby the tensile strength and resistance to cracking of the composite is preserved even at elevated temperatures of 900.degree. C. or higher.

Abstract: Yttrium-containing phosphors can be stabilized for use in an aqueous slurry containing a binder, which slurry can be used for coating fluorescent lamps by treating with ammonium dihydrogen phosphate and ammonium hydrogen difluoride to inactivate free yttrium ions. The resulting aqueous slurry is stable and provides coated fluorescent lamps having uniform coatings that are bright and long lasting.

Abstract: Yttrium-containing phosphors can be stabilized for use in an aqueous slurry containing a binder, which slurry can be used for coating fluorescent lamps by treating with ammonium dihydrogen phosphate and ammonium hydrogen difluoride to inactivate free yttrium ions. The resulting aqueous slurry is stable and provides coated fluorescent lamps having uniform coatings that are bright and long lasting.

Abstract: The superconducting material YBa.sub.2 Cu.sub.3 O.sub.7, which loses its superconducting qualities when exposed to water, is passivated against such water damage by a thin film on its surface comprised of a mixed phase which includes YBa.sub.2 Cu.sub.3 O.sub.(7-x) F.sub.2x, where 0<X.ltoreq.1/2.

Abstract: A conductive molding composition for the preparation of high density capacitance electronic discs is disclosed. The improved composition contains only five ingredients and is characterized by superior playback without the necessity of washing the disc after pressing. The subject compositions contain as a dispersant isopropyl tri(dioctylpyrophosphato)titanate. Preferred compositions are additionally comprised of poly(vinyl chloride), conductive carbon black, diundecyl phalthalate as a plasticizer and a tin mercaptoester or tin alkyl mercaptide stabilizer.

Abstract: A titanium coupling agent of the formula ##STR1## wherein R.sub.3 is methyl, ethyl or isopropyl and R.sub.4 and R.sub.5 are long chain alkyl groups of 8-20 carbon atoms, when added to a fractionated methyl alkyl siloxane lubricant for capacitive electronic discs, improves the playback performance of the discs.

Abstract: An improved conductive molding composition for the preparation of high density capacitance electronic discs is disclosed. The disclosed compositions are improved by the utilization of a solid plasticizer, cumylphenyl isophthalate, represented by the formula ##STR1## The use of this plasticizer permits the formulation of a conductive molding composition wherein all ingredients are solids.

Abstract: An improved conductive molding composition for the preparation of high density capacitance electronic discs is disclosed. The disclosed compositions are improved by the replacement of most or all of the conventionally used stabilizer ingredient with a tin mercapto ester or alkyl mercaptide represented by the formulae ##STR1## wherein R is a straight-chain alkyl radical having 4 to 8 carbon atoms; R.sub.1 is selected from --S-CH.sub.2 -COOR.sub.3 and --S-R.sub.3 ;R.sub.2 is R or R.sub.1 ; andR.sub.3 is a straight-chain alkyl radical having from 8 to 18 carbon atoms.

Abstract: Nickel stampers used for the molding of capacitive electronic discs are treated prior to use in the molding process by heating the stamper in the presence of an oxygen containing gas, at a temperature from about 220.degree. C. to about 300.degree. C. for 2 to 5 hours until a continuous protective oxide layer approximately 10-40 angstroms thick is formed on the surface of the stamper.